menstrual disorder; this is a spontaneous report received from a contactable reporter (consumer) from the regulatory agency (ra). regulatory number: gb-mhra-webcovid-202202160939287130-daku1 (ra). other case identifier: gb-mhra-adr 26609279 (ra). a 38 year-old female patient (not pregnant) received bnt162b2 (comirnaty), administration date 10aug2021 (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. relevant medical history included: "suspected covid-19" (not ongoing), notes: unsure when symptoms started, unsure when symptoms stopped. the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 1, manufacturer unknown), for covid-19 immunisation. the following information was reported: menstrual disorder (medically significant) with onset 30aug2021, outcome "not recovered", described as "menstrual disorder". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: no - negative covid-19 test. patient had not tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test

na

na